US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist
  • 11.400
  • -0.990-7.99%
Close Mar 25 16:00 ET
  • 10.990
  • -0.410-3.60%
Pre 04:06 ET
1.29BMarket Cap-3.38P/E (TTM)

About Dyne Therapeutics Company

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Company Profile

SymbolDYN
Company NameDyne Therapeutics
Listing DateSep 17, 2020
Issue Price19.00
Founded2017
CEOMr. John G. Cox
MarketNASDAQ
Employees191
Fiscal Year Ends12-31
Address830 Winter Street
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-786-8230
Websitehttp://www.dyne-tx.com

Company Executives

  • Name
  • Position
  • Salary
  • John G. Cox
  • Director, President and Chief Executive Officer
  • --
  • Dr. Oxana Beskrovnaya, PhD
  • Chief Scientific Officer
  • --
  • Wildon Farwell, M.D.,M.P.H.
  • Chief Medical Officer
  • --
  • Richard William Scalzo
  • Senior Vice President, Head of Finance and Administration, Principal Financial and Accounting Officer
  • --
  • Jason P. Rhodes
  • Chairman of the Board
  • 283.17K
  • Dr. Catherine Stehman-Breen, M.D.
  • Independent Director
  • 253.92K
  • Dr. Carlo Incerti
  • Independent Director
  • 250.17K
  • Edward M. Hurwitz, J.D.
  • Independent Director
  • 250.17K
  • Dirk Kersten
  • Independent Director
  • 262.67K
  • David Charles Lubner, C.P.A.,M.S.
  • Independent Director
  • 264.17K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CGCABLE
834639
+23.62%
KLT
831689
+21.72%
DAYU BIOLOGICAL
871970
+21.47%
4
Fujian Superpipe
300198
+20.16%
5
WuHan Hvsen Biotechnology
300871
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025